Antibiotice S.A. (BVB:ATB)

Market Cap	1.62B
Revenue (ttm)	669.82M
Net Income (ttm)	87.13M
Shares Out	671.34M
EPS (ttm)	0.13
PE Ratio	18.64
Forward PE	n/a
Dividend	0.02 (0.85%)
Ex-Dividend Date	Sep 25, 2025

Volume	42,499
Average Volume	84,288
Open	2.420
Previous Close	2.420
Day's Range	2.405 - 2.420
52-Week Range	1.750 - 3.440
Beta	0.21
RSI	41.66
Earnings Date	Nov 20, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,357
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.